Galecto, Inc.

Galecto, Inc.

Biotechnology • Healthcare • Copenhagen, Denmark • GLTO (NCM)

Galecto, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark.

45 70 70 52 10 Ole Maaloes Vej 3, Denmark

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Biotech brings in cancer drug veterans as it readies new antibody trial - Stock Titan
Stock Titan • Jan 6
Galecto appoints Sherwin Sattarzadeh as chief operating officer and issues warrant - Investing.com
Investing.com • Jan 6
Galecto appoints new chief operating officer, enhances leadership - TipRanks
TipRanks • Jan 6
Galecto (GLTO) Price Target Increased by 12.50% to 36.72 - Nasdaq
Nasdaq • Dec 21
GLTO Stock Rises A Whopping 632% Pre-Market, But Retail Investors Remain Cautious - Stocktwits
Stocktwits • Oct 7

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Galecto, Inc. had layoffs?
No layoff events have been recorded for Galecto, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Galecto, Inc. have?
Galecto, Inc. has approximately 5 employees.
What industry is Galecto, Inc. in?
Galecto, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Galecto, Inc. a publicly traded company?
Yes, Galecto, Inc. is publicly traded under the ticker symbol GLTO on the NCM. The company has a market capitalization of approximately $0.05 billion.
Where is Galecto, Inc. headquartered?
Galecto, Inc. is headquartered in Copenhagen, Denmark at Ole Maaloes Vej 3, Denmark.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.